Posters

One-year results of CyPass Micro-Stent implantation in conjunction with phacoemulsification in Madrid, Spain

Poster Details

First Author: J.García Feijoo SPAIN

Co Author(s):    J. Martínez de la Casa              

Abstract Details

Purpose:

To assess the safety and clinical outcomes of an ab interno supraciliary implant (CyPass Micro-Stent, Transcend Medical, Inc., Menlo Park, CA, USA) in patients with open-angle glaucoma (OAG) undergoing cataract surgery.

Setting:

Prospective, interventional consecutive case series in a single center.

Methods:

The CyPass Micro-Stent was implanted immediately following lens implantation through the same corneal incision into the supraciliary space using an ab interno approach. Intraocular pressure (IOP)-lowering medications were discontinued following the procedure. Depending on each subject's IOP target, medications were re-introduced at the investigator's discretion. Main outcomes were adverse events, IOP changes, and number of IOP-lowering medications.

Results:

Eyes (n=22) were enrolled in a single-site. All micro-stents were successfully implanted in the supraciliary space. There were no sight-threatening or major complications. At baseline (n=22), subjects had a mean ± SD IOP of 19.8 ± 5.3 mmHg on a mean ± SD of 1.9 ± 0.5 IOP-lowering medications. By 12 M (n=18), mean ± SD IOP was 16.8 ± 2.0 mmHg, on 0.2 ± 0.4 mean medications. At baseline, 82% of subjects were on 2 or more medications. At 12 M, 78% of subjects were on 0 medications, while the remaining 22% were on 1 medication, with no subjects on 2 or 3 medications.

Conclusions:

Implantation of the CyPass Micro-Stent in combination with cataract surgery results in minimal complications and reduction of IOP and IOP-lowering medications at 12M postoperatively. By reducing dependence on medications, the CyPass Micro-Stent has the potential to address challenging adherence issues many glaucoma patients face. FINANCIAL INTEREST: One of more of the authors... research is funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, One of more of the authors... research is funded, fully or partially, by a competing company